Project Grant R34DA061589
Award Date
8/1/24
Completion Date
6/30/27
Dollars Obligated
$630K
Federal Agency
National Institute on Drug Abuse
Federal Grant Program
93.279
Assistance Type
Project Grant
Place of Performance
Columbus, OH 43210, USA
Similar Awards
This Project Grant award of $390,000.00, provided by the National Institute on Drug Abuse under the Drug Use and Addiction Research Programs (CFDA 93.279), will support a pilot study to evaluate a digital Contingency Management (CM) intervention for Medicaid beneficiaries with co-occurring opioid and alcohol use disorders (OUD-AUD).
The key objectives are to: 1) identify optimal settings and approaches to engage this population in digital CM through Medicaid claims data analysis; 2) convene...
This Project Grant award from the National Institutes of Health's National Institute on Drug Abuse (CFDA 93.279 - Drug Use and Addiction Research Programs) in the amount of $385,000 will support research to advance integrated treatment for patients with co-occurring opioid use disorder (OUD) and alcohol use disorder (AUD). The key objectives of the project are to: 1) Assess the effectiveness of integrated treatment approaches, including first-line AUD/OUD medications and glucagon-like...
This Project Grant award, with a total funding amount of $958,629, was awarded by the National Institute on Drug Abuse (NIDA) under the Drug Abuse and Addiction Research Programs (CFDA 93.279). The funding will support the real-world adoption of an innovative digital health therapeutic called KIOS, which uses nonlinear control theory to track multiple symptoms (e.g., craving, mood, pain) and deliver personalized, evidence-based intervention strategies to patients with opioid use disorder...
This $304,023 Project Grant awarded by the National Institute on Drug Abuse (CFDA 93.279 - Drug Use and Addiction Research Programs) supports the development of a digital product called "RESHAPE" by Evidation Health, Inc. (dba Achievemint). The objective is to create a digital experience that addresses the health-related social needs (HRSN) impacting substance use disorder (SUD) recovery, including factors such as housing, food, transportation, and personal safety.
The 2-phase...
This $683,611 federal Project Grant award from the National Institute on Alcohol Abuse and Alcoholism (NIAAA) under the Alcohol Research Programs (CFDA 93.273) is funding research to optimize the components of smart digital therapeutic messaging for improving engagement and clinical outcomes for alcohol use disorder (AUD).
The project aims to embed machine learning-based lapse prediction models into an existing digital therapeutic platform (A-CHESS) and determine the optimal ways to provide...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $196,176 over 5 years to the Regents of the University of Michigan to optimize an app-based intervention to reduce cannabis and alcohol co-use among sexual minoritized emerging adults (SM EAs) attending college.
The overall research objective is to develop and test an adaptive, app-based intervention for this high-risk population. Key activities...
This Project Grant award of $421,499 from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) aims to develop a comprehensive model and measure of "intervention stigma" toward medication-based treatments for opioid use disorder (OUD). The project, titled "OPIOID USE DISORDER PHARMACEUTICAL TREATMENTS: INVESTIGATING A MODEL AND MEASURE OF INTERVENTION STIGMA TOWARD MEDICATION (OPTIMISM)", will leverage collaborations...
This $1,594,478 federal Project Grant award from the National Institutes of Health's Drug Use and Addiction Research Programs (CFDA 93.279) will fund a prospective, observational study by the University of Massachusetts Medical School (UMMS) to develop digital phenotypes of opioid use disorder (OUD) based on craving patterns during treatment with medications for OUD (MOUD). The study will monitor 300 participants starting MOUD therapy for approximately 60 days, using continuous wearable...
This National Institute on Drug Abuse (NIDA) Project Grant award under the Drug Use and Addiction Research Programs (CFDA 93.279) provides $913,261 to the Medical University of South Carolina to develop and evaluate a digital, decision-support toolkit to enhance screening, assessment, and referral for intimate partner violence (IPV) and co-occurring mental health conditions, such as post-traumatic stress disorder (PTSD), among individuals with opioid use disorder seeking care at opioid...
This Project Grant award, provided by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), aims to develop and evaluate a smart speaker-based application to support housing stability for individuals with substance use disorders (SUD). The $591,848 award to Oregon Research Behavioral Intervention Strategies, Inc. (doing business as Influents Innovations) will fund a proof-of-concept prototype that uses voice-based assistants to teach...